G2M | Next Generation IVD solutions for Genomics
Upasana Bajaj, PhD, is a seasoned professional in the field of genomics and biotechnology. Currently serving as the Product Manager for Domestic and Global at Genes2Me since May 2023, Upasana has previously held the role of Product Manager at Redcliffe Genetics from June 2022 to April 2023, and worked as a Product Application Specialist at Bio-Techne from December 2021 to May 2022. Upasana's academic background includes a Doctor of Philosophy in Cancer from the National University of Singapore, as well as a Bachelor's degree in Biomedical Sciences from Delhi University and a Master's degree in Biotechnology from Jamia Millia Islamia.
This person is not in any teams
G2M | Next Generation IVD solutions for Genomics
Genes2Me is India's leading IVD solutions manufacturer which offers NGS clinical panels, molecular POC testing solutions, RT-PCR kits, rapid antigen/antibody testing kits, and molecular biology reagents. Additionally, Company is also a renowned genetic testing service provider with a wide range of tests targeting infectious and non-infectious diseases, oncology, rare diseases, and prenatal/postnatal genetic diseases. NGS clinical assays from Genes2Me allow targeted testing for Oncology, Liquid Biopsy, cardiovascular conditions, neurological disorders, HLA typing, etc. With engaging innovative approaches and new ideas, the company’s flagship products Rapi-Q/ Rapi-Q HT and Rapid POC RT-PCR device are revolutionary innovations that shall change the paradigm of molecular Point of Care testing across the world. Brands: CliSeq NGS clinical panels, PanCan, Med4Me, Exome CliSeq, CliSeq LiqBio, Rapi-Q / Rapi-Q HT, Rapi-X 16, Rapi-X 96, RapiCycler 96, RT-Direct, CoviEasy, LeoNext